Saturday, May 28, 2016

CSIR launches ayurvedic anti-diabetic drug BGR-34 – Times of India

PUNE: An anti-diabetes Ayurvedic drug along with DPP4 inhibitory activity, BGR-34 status for Blood Sugar Regulator was launched by Council for Scientific and Industrial Study (CSIR) just recently in Pune. BGR-34, has actually been created for kind 2 diabetes mellitus and medically validated for its efficacy and protection said Dr A K S Rawat, principal senior scientist, CSIR- NBRI.

Developed jointly by National Botanical Study Institute (NBRI) and Main Institute for Medicinal and Aromatic Plants (CIMAP), the Study units of CSIR, Federal government of India, situated at Lucknow, BGR-34 has actually been economically priced at Rs 5 every tablet as compared to latest DPP4 inhibitors globally.

Dr Sanjeev Kumar Ojha, Senior Scientist, CSIR- NBRI, Lucknow, Dr Dayanandan Mani, Senior Scientist, CSIR- CIMAP, Lucknow, Dr Medha Kulkarni, Vice Principal, D Y Patil Ayurvedic College and Study Centre, Pune and S P Srivastav, Director, AIMIL Pharmaceuticals (India) Ltd were additionally present when it come to the occasion.

Speaking when it come to the occasion Dr Rawat, said “Concerning 6 crore of the adult Indian population has actually been discovered to be diabetic and there is no efficient program for diabetes as yet. We are sure that eminent clinical professionals will certainly advise BGR-34 to their patients suffering from kind 2 Diabetes mellitus for faster and constant response.”

“We researched in detail over 500 renowned ancient herbs and finally identified the 6 finest herbs listed in Ayurvedic ancient texts for different ailments and indications. The herbs were further subjected to optimization studies to establish the ideal proportion”, said Dr Mani, senior scientist, CSIR – CIMAP.

Pre-health care studies of this antidiabetic formulation discloses substantial reduction in higher blood glucose degree in diabetes induced experimental subjects, along with the task being comparable along with the reference standard anti-diabetic allopathic drug. Besides, the drug was discovered to increase LFTs, KFT’s and lipid profile considerably it additionally offers the a lot required pronounced antioxidant protective activity. health care studies along with BGR-34 have actually additionally revealed substantial anti-diabetic tasks along with no untoward effects observed.

Available when it come to all of serious chemist counters of Punjab, Chandigarh and adjoining states of India, BGR-34 will certainly now be Offered in Maharashtra as well. The medication aids in regulating Sugar and lipid Metabolism, reduces the opportunities of triopathic complications because of persistent higher blood Sugar and tones the functions of pancreas. It additionally checks over way too much thirst, urination and fatigue, imparting great high quality life.